Tuesday
May 27, 2025
4:15 PM ET
Evolus Announces Departure of its Chief Financial Officer
Wednesday
May 7, 2025
4:05 PM ET
Evolus Reports First Quarter 2025 Results
Monday
May 5, 2025
4:05 PM ET
Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility
Wednesday
April 23, 2025
8:00 AM ET
Evolus to Report First Quarter Financial Results on May 7, 2025
Tuesday
March 4, 2025
4:05 PM ET
Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance
Tuesday
February 18, 2025
8:00 AM ET
Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025
Thursday
February 13, 2025
1:30 PM ET
Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
Tuesday
January 21, 2025
8:00 AM ET
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company’s Guidance